TEVA FY 2014 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$35B

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$20.3B-0.2% YoY

Gross Profit

$11.1B54.5% margin

Operating Income

$4.0B19.5% margin

Net Income

$3.1B15.1% margin

EPS (Diluted)

$3.56

Cash Flow

Operating Cash Flow

$5.1B

Free Cash Flow

$4.2B

Stock-Based Comp.

$95M

Balance Sheet

Total Assets

$46.4B

Total Liabilities

$23.1B

Stockholders' Equity

$23.3B

Cash & Equivalents

$2.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20.3B	$20.3B	-0.2%
Gross Profit	$11.1B	$10.7B	+3.3%
Operating Income	$4.0B	$1.6B	+139.6%
Net Income	$3.1B	$1.3B	+140.7%